Resona Asset Management Co. Ltd. Has $16 Million Position in Cardinal Health, Inc. $CAH

Resona Asset Management Co. Ltd. cut its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 5.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 102,308 shares of the company’s stock after selling 5,890 shares during the period. Resona Asset Management Co. Ltd.’s holdings in Cardinal Health were worth $16,000,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of the company. SJS Investment Consulting Inc. grew its holdings in Cardinal Health by 1,363.6% during the third quarter. SJS Investment Consulting Inc. now owns 161 shares of the company’s stock worth $25,000 after purchasing an additional 150 shares during the period. Jones Financial Companies Lllp lifted its position in shares of Cardinal Health by 198.3% in the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after buying an additional 14,034 shares during the last quarter. Atlantic Edge Private Wealth Management LLC boosted its stake in shares of Cardinal Health by 75.0% during the 2nd quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock worth $29,000 after acquiring an additional 75 shares during the period. American Capital Advisory LLC increased its holdings in shares of Cardinal Health by 5,200.0% during the 3rd quarter. American Capital Advisory LLC now owns 212 shares of the company’s stock worth $33,000 after acquiring an additional 208 shares during the last quarter. Finally, Vermillion & White Wealth Management Group LLC raised its stake in Cardinal Health by 55.0% in the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 200 shares of the company’s stock valued at $34,000 after acquiring an additional 71 shares during the period. 87.17% of the stock is owned by institutional investors.

Cardinal Health Trading Up 0.7%

Shares of CAH stock opened at $208.29 on Monday. The stock has a market cap of $49.49 billion, a P/E ratio of 31.42, a price-to-earnings-growth ratio of 1.41 and a beta of 0.65. Cardinal Health, Inc. has a 1 year low of $120.72 and a 1 year high of $215.48. The stock has a 50 day simple moving average of $205.78 and a 200 day simple moving average of $176.35.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, beating the consensus estimate of $2.22 by $0.33. The firm had revenue of $64.01 billion during the quarter, compared to analysts’ expectations of $59.41 billion. Cardinal Health had a negative return on equity of 84.37% and a net margin of 0.68%.The company’s quarterly revenue was up 22.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.88 EPS. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. Analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd were paid a dividend of $0.5107 per share. This represents a $2.04 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date was Friday, January 2nd. Cardinal Health’s dividend payout ratio is presently 30.77%.

Analyst Ratings Changes

A number of equities analysts have commented on the stock. Barclays began coverage on shares of Cardinal Health in a research report on Monday, December 8th. They set an “overweight” rating and a $243.00 price objective for the company. Argus lifted their target price on shares of Cardinal Health from $211.00 to $232.00 and gave the stock a “buy” rating in a report on Friday. Wall Street Zen raised shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, November 8th. Wells Fargo & Company boosted their price objective on Cardinal Health from $221.00 to $237.00 and gave the stock an “overweight” rating in a report on Thursday, January 15th. Finally, Weiss Ratings reaffirmed a “buy (b)” rating on shares of Cardinal Health in a research report on Wednesday. Fourteen equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $221.07.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.